Cargando…
Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?
Colorectal cancer (CRC) is the third most common cancer in the Western world, with one-third of cases located in the rectum. Preoperative radiotherapy is the standard of care for many patients with rectal cancer but has a highly variable response rate. The ability to predict response would be of gre...
Autores principales: | Fischer, Jesse, Eglinton, Tim W., Frizelle, Frank A., Hampton, Mark B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210826/ https://www.ncbi.nlm.nih.gov/pubmed/30301137 http://dx.doi.org/10.3390/antiox7100136 |
Ejemplares similares
-
Readmission prediction after colorectal cancer surgery: A derivation and validation study
por: D’Souza, Joel, et al.
Publicado: (2023) -
Peroxiredoxins in Cancer and Response to Radiation Therapies
por: Forshaw, Tom E., et al.
Publicado: (2019) -
Incidence and risk factors for unplanned readmission after colorectal surgery: A meta-analysis
por: D’Souza, Joel, et al.
Publicado: (2023) -
Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II
por: Diaz, Anthony Joseph Gomez, et al.
Publicado: (2013) -
Peroxiredoxins and the Regulation of Cell Death
por: Hampton, Mark B., et al.
Publicado: (2016)